Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
| ▸ | MDK | P21741 | 3/20 | 0.42 |
| ▸ | BDNF | P23560 | 3/20 | 0.42 |
| ▸ | PTN | P21246 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.41 |
| ▸ | FGF1 | P05230 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20841393 | 0.90 | MAPK1 (0.44) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL19255224 | 0.88 | MAPK1 (0.47) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL19852803 | 0.88 | LGALS3 (0.45) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL26479163 | 0.87 | MDK (0.45) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL3044786 | 0.87 | CD69 (0.57) | MAPK1CD69MDKALDH1A1THRB | |
| SCHEMBL9541269 | 0.87 | CD69 (0.57) | MAPK1CD69MDKALDH1A1THRB | |
| SCHEMBL30259462 | 0.87 | CD69 (0.57) | MAPK1CD69MDKALDH1A1THRB | |
| SCHEMBL19892618 | 0.85 | MAPK1 (0.55) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL23280964 | 0.83 | LGALS3 (0.43) | MAPK1CD69MDKBDNFPTN | |
| SCHEMBL22137175 | 0.82 | LGALS3 (0.42) | MAPK1CD69MDKBDNFPTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180051100-A1 | Hyaluronic Acid Derivatives | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2018-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180051100-A1 | Hyaluronic Acid Derivatives | CD44, FUT6, FUT5 | MAPK1 3327/4885CD69 1142/4885MDK 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.